Amy Jamieson

VCH Clinical Title(s)

Gynecologic Oncologist

Research Focus

Sexual Health Uterine Cancer Vulvar Cancer

Contact Info

Biography

Dr. Amy Jamieson is an assistant professor in the Department of Obstetrics and Gynecology at the University of British Columbia (UBC) and a gynecologic oncologist at Vancouver General Hospital and BC Cancer. She completed her obstetrics and gynecology residency at the University of Otago and her gynecologic oncology fellowship at the University of Sydney and UBC. She was the first recipient of the Miller-Mindell Translational Research Fellowship with OVCARE and the Gynecologic Cancer Initiative. Her research is focused on molecular stratification and a subtype specific approach to endometrial and vulvar cancers.

Learn more about Dr. Jamieson’s research here.

News and Awards

Investigator Awards 2023 Recipients

Mar 21, 2023

Publications

Journal of the National Comprehensive Cancer Network : JNCCN -
Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.
Jamieson A, McAlpine JN
Gynecologic oncology -
Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.
Jamieson A, Huvila J, Leung S, Chiu D, Thompson EF, Lum A, Kinloch M, Helpman L, Salvador S, Vicus D, Kean S, Samouelian V, Grondin K, Irving J, Offman S, Parra-Herran C, Lau S, Scott S, Plante M, McConechy MK, Huntsman DG, Talhouk A, Kommoss S, Gilks CB, McAlpine JN
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc -
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.
Jamieson A, Huvila J, Chiu D, Thompson EF, Scott S, Salvador S, Vicus D, Helpman L, Gotlieb W, Kean S, Samouelian V, Köbel M, Kinloch M, Parra-Harran C, Offman S, Grondin K, Irving J, Lum A, Senz J, Leung S, McConechy MK, Plante M, Kommoss S, Huntsman DG, Talhouk A, Gilks CB, McAlpine JN
Gynecologic oncology -
The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype.
Jamieson A, Singh N, Huvila J, Gilks CB, McAlpine JN
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society -
Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma.
Thompson EF, Shum K, Wong RWC, Trevisan G, Senz J, Huvila J, Leung S, Huntsman DG, Gilks CB, McAlpine JN, Hoang L, Jamieson A

Amy Jamieson

Biography

News and Awards

Investigator Awards 2023 Recipients

Publications

Molecular Profiling of Endometrial Cancer From TCGA to Clinical Practice.

Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.

Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.

The continuing evolution of endometrial carcinoma molecular classification: Risk stratification within the No Specific Molecular Profile (NSMP) subtype.

Significance of p53 and presence of differentiated vulvar intra-epithelial neoplasia (dVIN) at resection margin in early stage human papillomavirus-independent vulvar squamous cell carcinoma.

Are you a researcher?